Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 198

1.

MicroRNA-155 governs SHIP-1 expression and localization in NK cells and regulates subsequent infiltration into murine AT3 mammary carcinoma.

Kandell WM, Donatelli SS, Trinh TL, Calescibetta AR, So T, Tu N, Gilvary DL, Chen X, Cheng P, Adams WA, Chen YK, Liu J, Djeu JY, Wei S, Eksioglu EA.

PLoS One. 2020 Feb 10;15(2):e0225820. doi: 10.1371/journal.pone.0225820. eCollection 2020.

2.

Immune evasion by TGFβ-induced miR-183 repression of MICA/B expression in human lung tumor cells.

Trinh TL, Kandell WM, Donatelli SS, Tu N, Tejera MM, Gilvary DL, Eksioglu EA, Burnette A, Adams WA, Liu J, Teer JK, Djeu JY, Coppola D, Wei S.

Oncoimmunology. 2019 Jan 17;8(4):e1557372. doi: 10.1080/2162402X.2018.1557372. eCollection 2019.

3.

Inhibition of Human Dendritic Cell ER Stress Response Reduces T Cell Alloreactivity Yet Spares Donor Anti-tumor Immunity.

Betts BC, Locke FL, Sagatys EM, Pidala J, Walton K, Menges M, Reff J, Saha A, Djeu JY, Kiluk JV, Lee MC, Kim J, Kang CW, Tang CH, Frieling J, Lynch CC, List A, Rodriguez PC, Blazar BR, Conejo-Garcia JR, Del Valle JR, Hu CC, Anasetti C.

Front Immunol. 2018 Dec 6;9:2887. doi: 10.3389/fimmu.2018.02887. eCollection 2018.

4.

Therapeutic targeting of myeloid-derived suppressor cells involves a novel mechanism mediated by clusterin.

Zhou J, Donatelli SS, Gilvary DL, Tejera MM, Eksioglu EA, Chen X, Coppola D, Wei S, Djeu JY.

Sci Rep. 2016 Jul 13;6:29521. doi: 10.1038/srep29521.

5.

Abscopal Benefits of Localized Radiotherapy Depend on Activated T-cell Trafficking and Distribution between Metastatic Lesions.

Poleszczuk JT, Luddy KA, Prokopiou S, Robertson-Tessi M, Moros EG, Fishman M, Djeu JY, Finkelstein SE, Enderling H.

Cancer Res. 2016 Mar 1;76(5):1009-18. doi: 10.1158/0008-5472.CAN-15-1423. Epub 2016 Feb 1.

6.

HMGB1 induction of clusterin creates a chemoresistant niche in human prostate tumor cells.

Zhou J, Chen X, Gilvary DL, Tejera MM, Eksioglu EA, Wei S, Djeu JY.

Sci Rep. 2015 Oct 15;5:15085. doi: 10.1038/srep15085.

7.

TGF-β-inducible microRNA-183 silences tumor-associated natural killer cells.

Donatelli SS, Zhou JM, Gilvary DL, Eksioglu EA, Chen X, Cress WD, Haura EB, Schabath MB, Coppola D, Wei S, Djeu JY.

Proc Natl Acad Sci U S A. 2014 Mar 18;111(11):4203-8. doi: 10.1073/pnas.1319269111. Epub 2014 Feb 28.

8.

Upregulation of miRNA-155 promotes tumour angiogenesis by targeting VHL and is associated with poor prognosis and triple-negative breast cancer.

Kong W, He L, Richards EJ, Challa S, Xu CX, Permuth-Wey J, Lancaster JM, Coppola D, Sellers TA, Djeu JY, Cheng JQ.

Oncogene. 2014 Feb 6;33(6):679-89. doi: 10.1038/onc.2012.636. Epub 2013 Jan 28.

9.

Tipifarnib-mediated suppression of T-bet-dependent signaling pathways.

Bai F, Villagra AV, Zou J, Painter JS, Connolly K, Blaskovich MA, Sokol L, Sebti S, Djeu JY, Loughran TP, Wei S, Sotomayor E, Epling-Burnette P.

Cancer Immunol Immunother. 2012 Apr;61(4):523-33. doi: 10.1007/s00262-011-1109-0. Epub 2011 Oct 9.

10.

Bone marrow mononuclear cells up-regulate toll-like receptor expression and produce inflammatory mediators in response to cigarette smoke extract.

Zhou J, Eksioglu EA, Fortenbery NR, Chen X, Wang H, Epling-Burnette PK, Djeu JY, Wei S.

PLoS One. 2011;6(6):e21173. doi: 10.1371/journal.pone.0021173. Epub 2011 Jun 29.

11.

Icariin and its derivative, ICT, exert anti-inflammatory, anti-tumor effects, and modulate myeloid derived suppressive cells (MDSCs) functions.

Zhou J, Wu J, Chen X, Fortenbery N, Eksioglu E, Kodumudi KN, Pk EB, Dong J, Djeu JY, Wei S.

Int Immunopharmacol. 2011 Jul;11(7):890-8. doi: 10.1016/j.intimp.2011.01.007. Epub 2011 Jan 15.

12.

A novel chemoimmunomodulating property of docetaxel: suppression of myeloid-derived suppressor cells in tumor bearers.

Kodumudi KN, Woan K, Gilvary DL, Sahakian E, Wei S, Djeu JY.

Clin Cancer Res. 2010 Sep 15;16(18):4583-94. doi: 10.1158/1078-0432.CCR-10-0733. Epub 2010 Aug 11.

13.

Induction of clusterin by AKT--role in cytoprotection against docetaxel in prostate tumor cells.

Zhong B, Sallman DA, Gilvary DL, Pernazza D, Sahakian E, Fritz D, Cheng JQ, Trougakos I, Wei S, Djeu JY.

Mol Cancer Ther. 2010 Jun;9(6):1831-41. doi: 10.1158/1535-7163.MCT-09-0880. Epub 2010 May 25.

14.

Clusterin and chemoresistance.

Djeu JY, Wei S.

Adv Cancer Res. 2009;105:77-92. doi: 10.1016/S0065-230X(09)05005-2. Review.

15.

A critical role for phosphatase haplodeficiency in the selective suppression of deletion 5q MDS by lenalidomide.

Wei S, Chen X, Rocha K, Epling-Burnette PK, Djeu JY, Liu Q, Byrd J, Sokol L, Lawrence N, Pireddu R, Dewald G, Williams A, Maciejewski J, List A.

Proc Natl Acad Sci U S A. 2009 Aug 4;106(31):12974-9. doi: 10.1073/pnas.0811267106. Epub 2009 May 26. Erratum in: Proc Natl Acad Sci U S A. 2013 Aug 27;110(35):14504.

16.

In contrast to anti-tumor activity, YT cell and primary NK cell cytotoxicity for Cryptococcus neoformans bypasses LFA-1.

Jones GJ, Wiseman JC, Marr KJ, Wei S, Djeu JY, Mody CH.

Int Immunol. 2009 Apr;21(4):423-32. doi: 10.1093/intimm/dxp010. Epub 2009 Mar 4.

PMID:
19261694
17.

Advances and challenges in basic and translational research on clusterin.

Trougakos IP, Djeu JY, Gonos ES, Boothman DA.

Cancer Res. 2009 Jan 15;69(2):403-6. doi: 10.1158/0008-5472.CAN-08-2912. No abstract available.

18.

A critical role for DAP10 and DAP12 in CD8+ T cell-mediated tissue damage in large granular lymphocyte leukemia.

Chen X, Bai F, Sokol L, Zhou J, Ren A, Painter JS, Liu J, Sallman DA, Chen YA, Yoder JA, Djeu JY, Loughran TP, Epling-Burnette PK, Wei S.

Blood. 2009 Apr 2;113(14):3226-34. doi: 10.1182/blood-2008-07-168245. Epub 2008 Dec 15.

19.

Bax-interacting factor-1 expression in prostate cancer.

Coppola D, Oliveri C, Sayegh Z, Boulware D, Takahashi Y, Pow-Sang J, Djeu JY, Wang HG.

Clin Genitourin Cancer. 2008 Sep;6(2):117-21. doi: 10.3816/CGC.2008.n.018.

20.

Clinical improvement by farnesyltransferase inhibition in NK large granular lymphocyte leukemia associated with imbalanced NK receptor signaling.

Epling-Burnette PK, Sokol L, Chen X, Bai F, Zhou J, Blaskovich MA, Zou J, Painter JS, Edwards TD, Moscinski L, Yoder JA, Djeu JY, Sebti S, Loughran TP Jr, Wei S.

Blood. 2008 Dec 1;112(12):4694-8. doi: 10.1182/blood-2008-02-136382. Epub 2008 Sep 12.

21.

Clusterin mediates TRAIL resistance in prostate tumor cells.

Sallman DA, Chen X, Zhong B, Gilvary DL, Zhou J, Wei S, Djeu JY.

Mol Cancer Ther. 2007 Nov;6(11):2938-47.

22.

Beta2 integrins separate graft-versus-host disease and graft-versus-leukemia effects.

Liang Y, Liu C, Djeu JY, Zhong B, Peters T, Scharffetter-Kochanek K, Anasetti C, Yu XZ.

Blood. 2008 Jan 15;111(2):954-62. Epub 2007 Oct 10.

23.

The zebrafish activating immune receptor Nitr9 signals via Dap12.

Wei S, Zhou JM, Chen X, Shah RN, Liu J, Orcutt TM, Traver D, Djeu JY, Litman GW, Yoder JA.

Immunogenetics. 2007 Oct;59(10):813-21. Epub 2007 Sep 21.

24.

Mechanism and therapeutic reversal of immune suppression in cancer.

Herber DL, Nagaraj S, Djeu JY, Gabrilovich DI.

Cancer Res. 2007 Jun 1;67(11):5067-9. No abstract available.

25.

Reduced natural killer (NK) function associated with high-risk myelodysplastic syndrome (MDS) and reduced expression of activating NK receptors.

Epling-Burnette PK, Bai F, Painter JS, Rollison DE, Salih HR, Krusch M, Zou J, Ku E, Zhong B, Boulware D, Moscinski L, Wei S, Djeu JY, List AF.

Blood. 2007 Jun 1;109(11):4816-24. Epub 2007 Mar 6.

26.

Novel role of Stat1 in the development of docetaxel resistance in prostate tumor cells.

Patterson SG, Wei S, Chen X, Sallman DA, Gilvary DL, Zhong B, Pow-Sang J, Yeatman T, Djeu JY.

Oncogene. 2006 Oct 5;25(45):6113-22. Epub 2006 May 1.

PMID:
16652143
27.

Immune-related, lectin-like receptors are differentially expressed in the myeloid and lymphoid lineages of zebrafish.

Panagos PG, Dobrinski KP, Chen X, Grant AW, Traver D, Djeu JY, Wei S, Yoder JA.

Immunogenetics. 2006 Feb;58(1):31-40. Epub 2006 Feb 9.

PMID:
16467987
28.

Small rho GTPases regulate antigen presentation in dendritic cells.

Shurin GV, Tourkova IL, Chatta GS, Schmidt G, Wei S, Djeu JY, Shurin MR.

J Immunol. 2005 Mar 15;174(6):3394-400.

29.

ERK couples chronic survival of NK cells to constitutively activated Ras in lymphoproliferative disease of granular lymphocytes (LDGL).

Epling-Burnette PK, Bai F, Wei S, Chaurasia P, Painter JS, Olashaw N, Hamilton A, Sebti S, Djeu JY, Loughran TP.

Oncogene. 2004 Dec 9;23(57):9220-9.

PMID:
15516985
30.

Resolution of the novel immune-type receptor gene cluster in zebrafish.

Yoder JA, Litman RT, Mueller MG, Desai S, Dobrinski KP, Montgomery JS, Buzzeo MP, Ota T, Amemiya CT, Trede NS, Wei S, Djeu JY, Humphray S, Jekosch K, Hernandez Prada JA, Ostrov DA, Litman GW.

Proc Natl Acad Sci U S A. 2004 Nov 2;101(44):15706-11. Epub 2004 Oct 20.

31.

Akt mediates Ras downregulation of RhoB, a suppressor of transformation, invasion, and metastasis.

Jiang K, Sun J, Cheng J, Djeu JY, Wei S, Sebti S.

Mol Cell Biol. 2004 Jun;24(12):5565-76.

32.

Dysregulated NK receptor expression in patients with lymphoproliferative disease of granular lymphocytes.

Epling-Burnette PK, Painter JS, Chaurasia P, Bai F, Wei S, Djeu JY, Loughran TP Jr.

Blood. 2004 May 1;103(9):3431-9. Epub 2004 Jan 15.

PMID:
14726391
33.

Carboxy-terminal truncated STAT5 is induced by interleukin-2 and GM-CSF in human neutrophils.

Epling-Burnette PK, Garcia R, Bai F, Ismail S, Loughran TP Jr, Djeu JY, Jove R, Wei S.

Cell Immunol. 2002 May-Jun;217(1-2):1-11.

PMID:
12425996
34.

Regulation of Akt-dependent cell survival by Syk and Rac.

Jiang K, Zhong B, Ritchey C, Gilvary DL, Hong-Geller E, Wei S, Djeu JY.

Blood. 2003 Jan 1;101(1):236-44. Epub 2002 Aug 29.

PMID:
12393431
35.

Blockade of Fas-dependent apoptosis by soluble Fas in LGL leukemia.

Liu JH, Wei S, Lamy T, Li Y, Epling-Burnette PK, Djeu JY, Loughran TP Jr.

Blood. 2002 Aug 15;100(4):1449-53.

PMID:
12149230
36.

Syk regulation of phosphoinositide 3-kinase-dependent NK cell function.

Jiang K, Zhong B, Gilvary DL, Corliss BC, Vivier E, Hong-Geller E, Wei S, Djeu JY.

J Immunol. 2002 Apr 1;168(7):3155-64.

37.

A view to a kill: signals triggering cytotoxicity.

Djeu JY, Jiang K, Wei S.

Clin Cancer Res. 2002 Mar;8(3):636-40. Review.

38.

Regulation of the mitogen-activated protein kinase signaling pathway by SHP2.

Cunnick JM, Meng S, Ren Y, Desponts C, Wang HG, Djeu JY, Wu J.

J Biol Chem. 2002 Mar 15;277(11):9498-504. Epub 2002 Jan 4.

39.

Cooperative regulation of Mcl-1 by Janus kinase/stat and phosphatidylinositol 3-kinase contribute to granulocyte-macrophage colony-stimulating factor-delayed apoptosis in human neutrophils.

Epling-Burnette PK, Zhong B, Bai F, Jiang K, Bailey RD, Garcia R, Jove R, Djeu JY, Loughran TP Jr, Wei S.

J Immunol. 2001 Jun 15;166(12):7486-95.

40.

Immune-type receptor genes in zebrafish share genetic and functional properties with genes encoded by the mammalian leukocyte receptor cluster.

Yoder JA, Mueller MG, Wei S, Corliss BC, Prather DM, Willis T, Litman RT, Djeu JY, Litman GW.

Proc Natl Acad Sci U S A. 2001 Jun 5;98(12):6771-6. Epub 2001 May 29.

41.

Pivotal role of phosphoinositide-3 kinase in regulation of cytotoxicity in natural killer cells.

Jiang K, Zhong B, Gilvary DL, Corliss BC, Hong-Geller E, Wei S, Djeu JY.

Nat Immunol. 2000 Nov;1(5):419-25. Erratum in: Nat Immunol 2000 Dec;1(6):541.

PMID:
11062502
42.

Retinoblastoma protein activation of interleukin 8 expression inhibits tumor cell survival in nude mice.

Zhang H, Wei S, Sun J, Coppola D, Zhong B, Wu GD, Goodwin B, Sebti S, Djeu JY, Blanck G.

Cell Growth Differ. 2000 Dec;11(12):635-9.

43.

IL-2 induces the association of IL-2Rbeta, lyn, and MAP kinase ERK-1 in human neutrophils.

Wei S, Liu JH, Epling-Burnette PK, Jiang K, Zhong B, Elkabani ME, Pearson EW, Djeu JY.

Immunobiology. 2000 Nov;202(4):363-82.

PMID:
11131153
44.

Direct tumor lysis by NK cells uses a Ras-independent mitogen-activated protein kinase signal pathway.

Wei S, Gilvary DL, Corliss BC, Sebti S, Sun J, Straus DB, Leibson PJ, Trapani JA, Hamilton AD, Weber MJ, Djeu JY.

J Immunol. 2000 Oct 1;165(7):3811-9.

45.

Chronic neutropenia mediated by fas ligand.

Liu JH, Wei S, Lamy T, Epling-Burnette PK, Starkebaum G, Djeu JY, Loughran TP.

Blood. 2000 May 15;95(10):3219-22.

PMID:
10807792
46.

Requirement for Ras/Rac1-mediated p38 and c-Jun N-terminal kinase signaling in Stat3 transcriptional activity induced by the Src oncoprotein.

Turkson J, Bowman T, Adnane J, Zhang Y, Djeu JY, Sekharam M, Frank DA, Holzman LB, Wu J, Sebti S, Jove R.

Mol Cell Biol. 1999 Nov;19(11):7519-28.

47.

Retinoblastoma protein expression leads to reduced Oct-1 DNA binding activity and enhances interleukin-8 expression.

Zhang H, Shepherd AT, Eason DD, Wei S, Diaz JI, Djeu JY, Wu GD, Blanck G.

Cell Growth Differ. 1999 Jul;10(7):457-65.

48.

Functional association of TGF-beta receptor II with cyclin B.

Liu JH, Wei S, Burnette PK, Gamero AM, Hutton M, Djeu JY.

Oncogene. 1999 Jan 7;18(1):269-75.

49.
50.

Supplemental Content

Support Center